Milk quality and subclinical mastitis in dairy herds in the province of Huaura, Lima Peru

El presente estudio se realizó en la provincia de Huaura, región Lima-Provincias, entre 2009 y 2010, y tuvo por objetivo determinar la calidad de leche mediante el Recuento de Células Somáticas (RCS), en tanques de leche de tres establos y cuatro asociaciones de pequeños ganaderos, en dos épocas del año. Asimismo, evaluar la mastitis subclínica en 32 establos (2100 vacas), utilizando la prueba de California Mastitis Test (CMT), teniendo en consideración el número de parto, tamaño del establo y momento de lactancia. No hubo diferencia estadística entre los RCS de establos (755.4 ± 46.9 x 103 células/ ml) con los valores de las asociaciones de pequeños ganaderos (752.1 ± 41.1 x 103 células/ ml); sin embargo hubo diferencias entre establos (p<0.05). El RCS en el verano (957.1 ± 54.1 x 103 células/ml) fue superior al obtenido en el invierno (550.3 ± 35.5 x 103 células/ml) (p< 0.05). Una mayor proporción de cuartos afectados con mastitis subclínica se observó en los establos medianos y grandes en comparación a los pequeños (52.6 y 49.9% vs 29.8%, respectivamente) (p<0.05), en vacas con más de dos partos en comparación a vacas con 1 y 2 partos (40.8, 32.8 y 24.8%, respectivamente) (p<0.05), y en vacas al final de lactancia en comparación a las de lactancia media e inicial (40.3, 38.2 y 23.2%, respectivamente) (p<0.05). La leche proveniente de los establos y asociaciones de ganaderos de la zona de Huaura no cumple las normas técnicas de calidad de la legislación peruana en términos de RCS. La mastitis subclínica estuvo asociada al tamaño del establo, número de parto y momento de lactancia.This research was conducted in the province of Huaura, Lima-Peru in 2009-2010 to determine the quality of milk through Somatic Cell Count (SCC) in milk tanks of three dairy herds and four small farmer associations in two seasons of the year, and to assess subclinical mastitis by the California Mastitis Test (CMT) in 32 farms (2100 cows), considering parity, herd size and lactation phase. No statistical difference was found between large dairy herds (755.4 ± 46.9 x 103 cells/ml) and farmer associations (752.1 ± 41.1 x 103 cells/ml); however, there were differences between farms (p <0.05). The RCS in summer (957.1 ± 54.1 x 103 cells/ml) was higher than in winter (550.3 ± 35.5 x 103 cells/ml) (p <0.05). A greater proportion of CMT positive quarters were observed in medium and large herds compared to small herds (52.6 and 49.9% vs 29.8% respectively) (p <0.05), in cows with >2 parities in comparison to 1st and 2nd calvers (40.8 vs 32.8 and 24.8% respectively) (p <0.05), and in cows in late lactation compared to mid and early lactation (40.3 vs 38.2, and 23.2% respectively) (p<0.05). Milk from Huaura dairy farms associations does not meet the Peruvian quality standards in terms of RCS. Subclinical mastitis was associated with herd size, parity, and time of lactation

Effect of chemical castration on the productive and behavioural performance of the guinea pig

El objetivo del estudio fue determinar el efecto de la castración química con tintura de yodo sobre el comportamiento productivo y conductual del cuy. Se utilizaron 24 cuyes cruzados Perú-Inti, de 25 a 35 días de edad, distribuidos en dos grupos: castrados y no castrados. La castración se realizó en la segunda semana del estudio por inyección intratesticular de tintura de yodo al 2% en dosis de 0.1 ml por testículo. Se evaluó el peso semanal y al beneficio, ganancia de peso diaria, y el número de peleas, a través de un diseño completamente al azar con covarianza por peso inicial. El peso semanal fue mayor en los castrados a partir de la cuarta semana del estudio (706.5 vs 648.8 g, p<0.05). El peso al beneficio (837.9 vs 738.4 g) y la ganancia de peso diaria (9.06 vs 6.94 g) fueron mayores en los animales castrados (p<0.01). El número de peleas registradas (7.8 vs 14.4) fue menor en los castrados (p<0.01). Se concluye que la castración química mejora el peso al beneficio y disminuye la conducta agresiva de los cuyes favoreciendo una mejor presentación de la carcasa.The objective of the study was to determine the effect of chemical castration using iodine tincture on the productive and behavioral performance of the guinea pig. Twenty four crossbred Peru-Inti guinea pigs from 25 to 35 days of age were used and allocated in two groups: castrated and non-castrated. Iodine tincture at 2%, dose of 0.1 ml per testicle, was used for the castration at the second week of the study. Weekly body weight and at slaughter, daily body weight gain, and number of fights were evaluated using a completely randomized design with covariance for initial body weight. Weekly body weight was higher in castrated animals from the fourth week of the study (706.5 vs 648.8 g) onwards (p<0.05). Body weight at slaughter (837.9 vs 738.40 g) and daily body weight gain (9.06 vs 6.94 g) were higher in the castrated (p<0.01). The number of fights (7.8 vs14.4) was lower in castrated animals (p<0.01). The chemical castration increases body weight at slaughtering and reduce the aggressive behavior of guinea pigs improving the presentation of the carcasses

Relación entre la apnea obstructiva del sueño y el intervalo Q-Tc prolongado del electrocardiograma

Durante la apnea obstructiva del sueño se presentan alteracionesde los parámetros fisiológicos y entre ellas ocupanun lugar destacado las relacionadas con arritmias cardíacas,las cuales están asociadas con prolongaciones del intervaloQ-T corregido, fenómeno de trascendental importanciahabida consideración de su asociación con muertes súbitas.El grupo de investigación en electrofisiología de la UTPpretende demostrar dicha relación mediante el análisis deseñales de registros electrocardiográficos de pacientes conapnea obstructiva del sueño

Relación entre la apnea obstructiva del sueño y el intervalo Q-Tc prolongado del electrocardiograma

Durante la apnea obstructiva del sueño se presentan alteracionesde los parámetros fisiológicos y entre ellas ocupanun lugar destacado las relacionadas con arritmias cardíacas,las cuales están asociadas con prolongaciones del intervaloQ-T corregido, fenómeno de trascendental importanciahabida consideración de su asociación con muertes súbitas.El grupo de investigación en electrofisiología de la UTPpretende demostrar dicha relación mediante el análisis deseñales de registros electrocardiográficos de pacientes conapnea obstructiva del sueño

Optomechanical devides for mechanobiological fingerprinting

Resumen del trabajo presentado en el Frontiers of Nanomechanical Systems (FSN2021), celebraod de forma virtual del 19 al 21 de enero de 2021Twenty years have passed since the first detection of biomolecular recognition using micromechanical systems[1]. In the last two decades, micro- nanomechanical systems have been refined to achieve amazing detection limits in force and mass that have enabled different schemes for ultrasensitive measurements of biological interactions as well as new ways of biological spectrometry. More recently, these figures of merit have been improved by coupling optical cavities to mechanical systems. In this talk, I will review the use of micro- nanomechanical systems for mechanobiological fingerprinting of biological entities, particularizing in the contributions of our group [2]. An essential core of this topic is the discussion about the mechanical coupling between a biological particle and a mechanical resonator, an issue that it is has been often oversimplified. We show that the biomechanical coupling that emerges between a bioparticle and a mechanical resonator is more complex than previously expect and it can give rise to different interaction regimes, in which the resonator response is dominated by different physical parameters of the analyte [3-4]. In particular, we will show experiments done with a variety of micro- nano- optomechanical systems using different measurement schemes where the mass, the stiffness and even the vibration modes of single biological entities can be measured with high sensitivity. It is now widely appreciated the essential role of mechanics in relevant biological processes and how disease can be revealed as changes in the mechanical properties of biological matter. I am pretty sure that future developments in optomechanical devices will contribute for major understanding of diseases as well as for new avenues in diagnosis and therapy

Multiple Local and Recent Founder Effects of TGM1 in Spanish Families

<div><h3>Background</h3><p>Mutations in the <em>TGM1</em> gene encoding transglutaminase 1 are a major cause of autosomal recessive congenital ichthyosis. In the Galician (NW Spain) population, three mutations, c.2278C>T, c.1223_1227delACAC and c.984+1G>A, were observed at high frequency, representing ∼46%, ∼21% and ∼13% of all <em>TGM1</em> gene mutations, respectively. Moreover, these mutations were reported only once outside of Galicia, pointing to the existence of historical episodes of local severe genetic drift in this region.</p> <h3>Methodology/Principal Findings</h3><p>In order to determine whether these mutations were inherited from a common ancestor in the Galician population, and to estimate the number of generations since their initial appearance, we carried out a haplotype-based analysis by way of genotyping 21 SNPs within and flanking the <em>TGM1</em> gene and 10 flanking polymorphic microsatellite markers spanning a region of 12 Mb. Two linkage disequilibrium based methods were used to estimate the time to the most recent common ancestor (TMRCA), while a Bayesian-based procedure was used to estimate the age of the two mutations. Haplotype reconstruction from unphased genotypes of all members of the affected pedigrees indicated that all carriers for each of the two mutations harbored the same haplotypes, indicating common ancestry.</p> <h3>Conclusions/Significance</h3><p>In good agreement with the documentation record and the census, both mutations arose between 2,800–2,900 years ago (y.a.), but their TMRCA was in the range 600–1,290 y.a., pointing to the existence of historical bottlenecks in the region followed by population growth. This demographic scenario finds further support on a Bayesian Coalescent Analysis based on <em>TGM1</em> haplotypes that allowed estimating the occurrence of a dramatic reduction of effective population size around 900–4,500 y.a. (95% highest posterior density) followed by exponential growth.</p> </div

A prospective cohort study to assess seroprevalence, incidence, knowledge, attitudes and practices, willingness to pay for vaccine and related risk factors in dengue in a high incidence setting

Abstract Background Dengue is one of the most important vector-borne diseases in the world, causing significant morbidity and economic impact. In Colombia, dengue is a major public health problem. Departments of La Guajira, Cesar and Magdalena are dengue endemic areas. The objective of this research is to determine the seroprevalence and the incidence of dengue virus infection in the participating municipalities from these Departments, and also establish the association between individual and housing factors and vector indices with seroprevalence and incidence. We will also assess knowledge, attitudes and practices, and willingness-to-pay for dengue vaccine. Methods A cohort study will be assembled with a clustered multistage sampling in 11 endemic municipalities. Approximately 1000 homes will be visited to enroll people older than one year who living in these areas, who will be followed for 1 year. Dengue virus infections will be evaluated using IgG indirect ELISA and IgM and IgG capture ELISA. Additionally, vector indices will be measured, and adult mosquitoes will be captured with aspirators. Ovitraps will be used for continuous estimation of vector density. Discussion This research will generate necessary knowledge to design and implement strategies with a multidimensional approach that reduce dengue morbidity and mortality in La Guajira and other departments from Colombian Caribbean

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Amplified Genes May Be Overexpressed, Unchanged, or Downregulated in Cervical Cancer Cell Lines

Several copy number-altered regions (CNAs) have been identified in the genome of cervical cancer, notably, amplifications of 3q and 5p. However, the contribution of copy-number alterations to cervical carcinogenesis is unresolved because genome-wide there exists a lack of correlation between copy-number alterations and gene expression. In this study, we investigated whether CNAs in the cell lines CaLo, CaSki, HeLa, and SiHa were associated with changes in gene expression. On average, 19.2% of the cell-line genomes had CNAs. However, only 2.4% comprised minimal recurrent regions (MRRs) common to all the cell lines. Whereas 3q had limited common gains (13%), 5p was entirely duplicated recurrently. Genome-wide, only 15.6% of genes located in CNAs changed gene expression; in contrast, the rate in MRRs was up to 3 times this. Chr 5p was confirmed entirely amplified by FISH; however, maximum 33.5% of the explored genes in 5p were deregulated. In 3q, this rate was 13.4%. Even in 3q26, which had 5 MRRs and 38.7% recurrently gained SNPs, the rate was only 15.1%. Interestingly, up to 19% of deregulated genes in 5p and 73% in 3q26 were downregulated, suggesting additional factors were involved in gene repression. The deregulated genes in 3q and 5p occurred in clusters, suggesting local chromatin factors may also influence gene expression. In regions amplified discontinuously, downregulated genes increased steadily as the number of amplified SNPs increased (p<0.01, Spearman's correlation). Therefore, partial gene amplification may function in silencing gene expression. Additional genes in 1q, 3q and 5p could be involved in cervical carcinogenesis, specifically in apoptosis. These include PARP1 in 1q, TNFSF10 and ECT2 in 3q and CLPTM1L, AHRR, PDCD6, and DAP in 5p. Overall, gene expression and copy-number profiles reveal factors other than gene dosage, like epigenetic or chromatin domains, may influence gene expression within the entirely amplified genome segments

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants

BACKGROUND: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-standardised adult prevalence of diabetes at its 2010 levels. We aimed to estimate worldwide trends in diabetes, how likely it is for countries to achieve the global target, and how changes in prevalence, together with population growth and ageing, are affecting the number of adults with diabetes. METHODS: We pooled data from population-based studies that had collected data on diabetes through measurement of its biomarkers. We used a Bayesian hierarchical model to estimate trends in diabetes prevalence—defined as fasting plasma glucose of 7·0 mmol/L or higher, or history of diagnosis with diabetes, or use of insulin or oral hypoglycaemic drugs—in 200 countries and territories in 21 regions, by sex and from 1980 to 2014. We also calculated the posterior probability of meeting the global diabetes target if post-2000 trends continue. FINDINGS: We used data from 751 studies including 4 372 000 adults from 146 of the 200 countries we make estimates for. Global age-standardised diabetes prevalence increased from 4·3% (95% credible interval 2·4–7·0) in 1980 to 9·0% (7·2–11·1) in 2014 in men, and from 5·0% (2·9–7·9) to 7·9% (6·4–9·7) in women. The number of adults with diabetes in the world increased from 108 million in 1980 to 422 million in 2014 (28·5% due to the rise in prevalence, 39·7% due to population growth and ageing, and 31·8% due to interaction of these two factors). Age-standardised adult diabetes prevalence in 2014 was lowest in northwestern Europe, and highest in Polynesia and Micronesia, at nearly 25%, followed by Melanesia and the Middle East and north Africa. Between 1980 and 2014 there was little change in age-standardised diabetes prevalence in adult women in continental western Europe, although crude prevalence rose because of ageing of the population. By contrast, age-standardised adult prevalence rose by 15 percentage points in men and women in Polynesia and Micronesia. In 2014, American Samoa had the highest national prevalence of diabetes (>30% in both sexes), with age-standardised adult prevalence also higher than 25% in some other islands in Polynesia and Micronesia. If post-2000 trends continue, the probability of meeting the global target of halting the rise in the prevalence of diabetes by 2025 at the 2010 level worldwide is lower than 1% for men and is 1% for women. Only nine countries for men and 29 countries for women, mostly in western Europe, have a 50% or higher probability of meeting the global target. INTERPRETATION: Since 1980, age-standardised diabetes prevalence in adults has increased, or at best remained unchanged, in every country. Together with population growth and ageing, this rise has led to a near quadrupling of the number of adults with diabetes worldwide. The burden of diabetes, both in terms of prevalence and number of adults affected, has increased faster in low-income and middle-income countries than in high-income countries. FUNDING: Wellcome Trust